Renaissance Technologies’s CollPlant Biotechnologies CLGN Stock Holding History

Renaissance Technologies’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.01K	Sell	16,800 -800	-5%	-$807	﹤0.01%	3201
2025 Q4	$24.6K	Sell	17,600 -4,300	-20%	-$8.8K	﹤0.01%	3134
2025 Q3	$58.9K	Sell	21,900 -19,700	-47%	-$47K	﹤0.01%	3320
2025 Q2	$56.6K	Buy	41,600 +31,300	+304%	+$64.8K	﹤0.01%	3378
2025 Q1	$26.6K	Sell	10,300 -300	-3%	-$1.06K	﹤0.01%	3346
2024 Q4	$38.2K	Buy	+10,600	New	+$43.1K	﹤0.01%	3421
2021 Q4	–	Sell	-10,001	Closed	-$169K	–	3934
2021 Q3	$169K	Buy	+10,001	New	+$180K	﹤0.01%	3235
2020 Q4	–	Sell	-12,797	Closed	-$107K	–	3411
2020 Q3	$107K	Buy	12,797 +100	+0.8%	+$900	﹤0.01%	3209
2020 Q2	$127K	Buy	+12,697	New	+$131K	﹤0.01%	3238

Other funds holding CLGN

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LWMI

Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

WPC

Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Renaissance Technologies's CLGN Position: Q1 2026 in Review

Renaissance Technologies reduced its CollPlant Biotechnologies (CLGN) stake by 4.5% in Q1 2026, selling an estimated $807 and leaving 16,800 shares worth $9.01K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Renaissance Technologies first reported a position in CLGN in Q2 2020 and has held it in 9 quarters since. The position peaked at $169K in Q3 2021. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

Renaissance Technologies held 16,800 shares of CollPlant Biotechnologies worth $9.01K as of Q1 2026.
Renaissance Technologies sold 800 CollPlant Biotechnologies shares in Q1 2026, an estimated $807.
CollPlant Biotechnologies made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3201 holding.
Renaissance Technologies first reported a position in CollPlant Biotechnologies in Q2 2020 and has held it in 9 quarters since.
Renaissance Technologies's CollPlant Biotechnologies position peaked at $169K in Q3 2021.
21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.